| Risk mapping for COVID-19 outbreaks in Australia using mobility data C Zachreson, L Mitchell, MJ Lydeamore, N Rebuli, M Tomko, N Geard Journal of the Royal Society Interface 18 (174), 20200657, 2021 | 51 | 2021 |
| Understanding how Victoria, Australia gained control of its second COVID-19 wave JM Trauer, MJ Lydeamore, GW Dalton, D Pilcher, MT Meehan, ... Nature Communications 12 (1), 6266, 2021 | 32 | 2021 |
| A biological model of scabies infection dynamics and treatment informs mass drug administration strategies to increase the likelihood of elimination MJ Lydeamore, PT Campbell, DG Regan, SYC Tong, RM Andrews, ... Mathematical biosciences 309, 163-173, 2019 | 25 | 2019 |
| Burden of five healthcare associated infections in Australia MJ Lydeamore, BG Mitchell, T Bucknall, AC Cheng, PL Russo, ... Antimicrobial Resistance & Infection Control 11 (1), 69, 2022 | 22 | 2022 |
| Indigenous Australian household structure: a simple data collection tool and implications for close contact transmission of communicable diseases T Vino, GR Singh, B Davison, PT Campbell, MJ Lydeamore, A Robinson, ... PeerJ 5, e3958, 2017 | 22 | 2017 |
| COVID-19 in low-tolerance border quarantine systems: impact of the Delta variant of SARS-CoV-2 C Zachreson, FM Shearer, DJ Price, MJ Lydeamore, J McVernon, ... Science Advances 8 (14), eabm3624, 2022 | 17 | 2022 |
| High burden of infectious disease and antibiotic use in early life in Australian Aboriginal communities W Cuningham, J McVernon, MJ Lydeamore, RM Andrews, J Carapetis, ... Australian and New Zealand journal of public health 43 (2), 149-155, 2019 | 17 | 2019 |
| Calculation of the age of the first infection for skin sores and scabies in five remote communities in northern Australia MJ Lydeamore, PT Campbell, W Cuningham, RM Andrews, T Kearns, ... Epidemiology & Infection 146 (9), 1194-1201, 2018 | 17 | 2018 |
| Bringing evidence from press release to the clinic in the era of COVID-19 JH McMahon, MJ Lydeamore, AJ Stewardson Journal of Antimicrobial Chemotherapy, 2020 | 14 | 2020 |
| COVID-19 vaccine coverage targets to inform reopening plans in a low incidence setting E Conway, CR Walker, C Baker, MJ Lydeamore, GE Ryan, T Campbell, ... Proceedings of the Royal Society B 290 (2005), 20231437, 2023 | 13 | 2023 |
| Analyses to predict the efficacy and waning of vaccines and previous infection against transmission and clinical outcomes of SARS-CoV-2 variants N Golding, M Lydeamore See https://github. com/goldingn/neuts2efficacy (accessed 5 April 2022), 2022 | 10 | 2022 |
| Estimation of the force of infection and infectious period of skin sores in remote Australian communities using interval-censored data MJ Lydeamore, PT Campbell, DJ Price, Y Wu, AJ Marcato, W Cuningham, ... PLoS Computational Biology 16 (10), e1007838, 2020 | 10 | 2020 |
| Estimating the impact of test–trace–isolate–quarantine systems on SARS-CoV-2 transmission in Australia FM Shearer, JM McCaw, GE Ryan, T Hao, NJ Tierney, MJ Lydeamore, ... Epidemics 47, 100764, 2024 | 7 | 2024 |
| The incidence of nosocomial bloodstream infection and urinary tract infection in Australian hospitals before and during the COVID-19 pandemic: an interrupted time series study BG Mitchell, AJ Stewardson, L Kerr, JK Ferguson, S Curtis, L Busija, ... Antimicrobial Resistance & Infection Control 12 (1), 61, 2023 | 6 | 2023 |
| Doherty institute modelling report for national cabinet J McVernon, DJ Price, PT Campbell, N Golding, CM Baker, J Walker, ... Melbourne: The Peter Doherty Institute for Infection and Immunity, 2021 | 5 | 2021 |
| Choice of antiviral allocation scheme for pandemic influenza depends on strain transmissibility, delivery delay and stockpile size M Lydeamore, N Bean, AJ Black, JV Ross Bulletin of mathematical biology 78, 293-321, 2016 | 3 | 2016 |
| Modelling the impact of hybrid immunity on future COVID-19 epidemic waves TP Le, I Abell, E Conway, PT Campbell, AB Hogan, MJ Lydeamore, ... BMC Infectious Diseases 24 (1), 1-14, 2024 | 2 | 2024 |
| Opportunities to strengthen respiratory virus surveillance systems in Australia: lessons learned from the COVID-19 response FM Shearer, L Edwards, M Kirk, O Eales, N Golding, J Hassall, B Liu, ... Communicable Diseases Intelligence 48, 2024 | 2 | 2024 |
| Cost-effective boosting allocations in the post-Omicron era of COVID-19 management TP Le, E Conway, E Akpan, I Abell, P Abraham, CM Baker, PT Campbell, ... medRxiv, 2023.11. 14.23298536, 2023 | 2 | 2023 |
| Mechanistic and Statistical Models of Skin Disease Transmission MJ Lydeamore The University of Melbourne, 2018 | 2 | 2018 |
Jodie McVernonUniversity of Melbourne, Murdoch Childrens Research InstituteVerified email at mcri.edu.au
